Breaking News Instant updates and real-time market news.

ALNY

Alnylam

$97.40

3.13 (3.32%)

12:59
08/10/18
08/10
12:59
08/10/18
12:59

FDA approves Alnylam's Onpattro as hATTR treatment

  • 11

    Aug

  • 15

    Aug

  • 25

    Aug

  • 30

    Aug

  • 31

    Aug

  • 04

    Sep

  • 11

    Sep

ALNY Alnylam
$97.40

3.13 (3.32%)

08/03/18
PIPR
08/03/18
NO CHANGE
Target $160
PIPR
Overweight
Piper sees FDA approval for Alnylam August 11 action date
Piper Jaffray analyst Edward Tenthoff is encouraged by the "broad opinion" from the U.K.'s Medicines and Healthcare Products Regulatory Agency for hATTR amyloidosis. The analyst continues to expect FDA approval of Onpattro to treat hATTR amyloidosis by next Saturday's August 11 action date. Tenthoff reiterates an Overweight rating on Alnylam Pharmaceuticals with a $160 price target.
08/06/18
STFL
08/06/18
UPGRADE
STFL
Buy
Alnylam upgraded to Buy from Hold at Stifel
08/07/18
08/07/18
UPGRADE
Target $125

Buy
Alnylam upgraded to Buy with $125 price target at Stifel
As previously reported, Stifel transferred coverage of Alnylam to analyst Paul Matteis, who set a Buy rating and $125 price target on the shares, up from the firm's prior Hold rating. He cites a series of upcoming, likely positive pipeline events for givosiran, lumasiran and ALN-TTRsc02 along with his confidence in Alnylam's ability to have a dominant position in the TTR amyloidosis market over the longer-term.
08/07/18
08/07/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. SeaWorld (SEAS) upgraded to Neutral from Underperform at Macquarie with analyst Matthew Brooks saying management is executing well, 1H 2018 attendance growth was impressive, and a new 2020 EBITDA goal heading into a seasonally strong period changes is cautious thesis. 2. Alnylam (ALNY) upgraded to Buy from Hold at Stifel with analyst Paul Matteis citing a series of upcoming, likely positive pipeline events for givosiran, lumasiran and ALN-TTRsc02 along with his confidence in Alnylam's ability to have a dominant position in the TTR amyloidosis market over the longer-term. 3. NeoPhotonics (NPTN) upgraded to Buy from Neutral at B. Riley FBR with analyst Dave Kang saying he sees improving fundamentals and increased his estimates following the company's Q2 results. 4. Illumina (ILMN) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Steve Beuchaw saying his prior thesis overestimated the impact of new products such as NovaSeq on utilization of the legacy installed base and failed to value critical new markets. 5. MasTec (MTZ) upgraded to Outperform from Neutral at Baird with analyst Andrew Wittmann saying concerns of weak cash flow and the MVP project work stoppage have already been priced into the stock and now offer a potential catalyst for the shares. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

IQ

iQIYI

$19.08

-0.43 (-2.20%)

, GOOG

Alphabet

$1,026.00

7 (0.69%)

05:28
11/21/18
11/21
05:28
11/21/18
05:28
Hot Stocks
iQIYI announces DRM partnership with Google »

iQIYI (IQ) announced that…

IQ

iQIYI

$19.08

-0.43 (-2.20%)

GOOG

Alphabet

$1,026.00

7 (0.69%)

GOOGL

Alphabet Class A

$1,031.22

4.99 (0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 04

    Dec

  • 03

    Mar

MRKR

Marker Therapeutics

$6.26

-0.42 (-6.29%)

05:28
11/21/18
11/21
05:28
11/21/18
05:28
Initiation
Marker Therapeutics initiated  »

Marker Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 07

    Dec

BZUN

Baozun

$30.07

-0.98 (-3.16%)

05:26
11/21/18
11/21
05:26
11/21/18
05:26
Earnings
Breaking Earnings news story on Baozun »

Baozun sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

BZUN

Baozun

$30.07

-0.98 (-3.16%)

05:25
11/21/18
11/21
05:25
11/21/18
05:25
Earnings
Baozun reports Q3 EPS 13c, consensus 11c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

BZUN

Baozun

$30.07

-0.98 (-3.16%)

, LITB

LightInTheBox

$1.10

(0.00%)

05:24
11/21/18
11/21
05:24
11/21/18
05:24
Hot Stocks
Baozun appoints Robin Lu as CFO »

Baozun announced that…

BZUN

Baozun

$30.07

-0.98 (-3.16%)

LITB

LightInTheBox

$1.10

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

ZLAB

Zai Lab

$17.00

-0.2 (-1.16%)

05:23
11/21/18
11/21
05:23
11/21/18
05:23
Initiation
Zai Lab initiated  »

Zai Lab initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NAVI

Navient

$10.74

-1.255 (-10.47%)

05:21
11/21/18
11/21
05:21
11/21/18
05:21
Hot Stocks
Navient CEO sends letter to holders in response to AP article »

Navient released the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

TEDU

Tarena

$7.26

-0.995 (-12.06%)

05:21
11/21/18
11/21
05:21
11/21/18
05:21
Downgrade
Tarena rating change  »

Tarena downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABIL

Ability

$2.83

-0.15 (-5.03%)

05:17
11/21/18
11/21
05:17
11/21/18
05:17
Hot Stocks
Ability to acquire supplier of principal cellular interception system »

Ability announced that,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INVVY

Indivior

$0.00

(0.00%)

05:16
11/21/18
11/21
05:16
11/21/18
05:16
Downgrade
Indivior rating change  »

Indivior downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFODF

Premier Foods

$0.00

(0.00%)

05:15
11/21/18
11/21
05:15
11/21/18
05:15
Upgrade
Premier Foods rating change  »

Premier Foods upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SE

Sea Limited

$12.18

-0.52 (-4.09%)

05:12
11/21/18
11/21
05:12
11/21/18
05:12
Recommendations
Sea Limited analyst commentary  »

Sea Limited posted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADSK

Autodesk

$122.99

-2.76 (-2.19%)

05:09
11/21/18
11/21
05:09
11/21/18
05:09
Recommendations
Autodesk analyst commentary  »

Autodesk price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 04

    Dec

ANAB

AnaptysBio

$68.73

0.8 (1.18%)

05:03
11/21/18
11/21
05:03
11/21/18
05:03
Initiation
AnaptysBio initiated  »

AnaptysBio initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DXCM

DexCom

$119.89

-1.34 (-1.11%)

, GOOG

Alphabet

$1,026.00

7 (0.69%)

05:01
11/21/18
11/21
05:01
11/21/18
05:01
Hot Stocks
DexCom, Alphabet's Verily amend collaboration and license agreement »

DexCom (DXCM) and Verily,…

DXCM

DexCom

$119.89

-1.34 (-1.11%)

GOOG

Alphabet

$1,026.00

7 (0.69%)

GOOGL

Alphabet Class A

$1,031.22

4.99 (0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 28

    Nov

  • 04

    Dec

  • 03

    Mar

ADI

Analog Devices

$89.12

3.57 (4.17%)

04:55
11/21/18
11/21
04:55
11/21/18
04:55
Recommendations
Analog Devices analyst commentary  »

Analog Devices price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

04:55
11/21/18
11/21
04:55
11/21/18
04:55
General news
Jobless Claims to be reported at 08:30 »

Week of 11/17 Jobless…

ELEZY

Endesa

$0.00

(0.00%)

04:55
11/21/18
11/21
04:55
11/21/18
04:55
Conference/Events
Endesa to hold a webcast »

Strategic plan update…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

04:55
11/21/18
11/21
04:55
11/21/18
04:55
General news
Leading Indicators to be reported at 10:00 »

October Leading…

04:55
11/21/18
11/21
04:55
11/21/18
04:55
General news
Breaking General news story  »

Week of 11/16 MBA…

04:55
11/21/18
11/21
04:55
11/21/18
04:55
General news
Consumer Sentiment Index to be reported at 10:00 »

Consumer Sentiment Index…

04:55
11/21/18
11/21
04:55
11/21/18
04:55
General news
Breaking General news story  »

Week of 11/16 EIA…

04:55
11/21/18
11/21
04:55
11/21/18
04:55
General news
Breaking General news story  »

Week of 11/16 EIA Natural…

04:55
11/21/18
11/21
04:55
11/21/18
04:55
General news
Durable Goods Orders Ex-transportation to be reported at 08:30 »

October Durable Goods…

04:55
11/21/18
11/21
04:55
11/21/18
04:55
Conference/Events
JPMorgan to hold a conference »

Best of British…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.